Form 4: Cyclerion Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Regina Margaret Graul, See Remarks and a Director of Cyclerion Therapeutics, Inc., reported multiple transactions in common stock on August 14, 2026.
Summary
- Option exercise/conversion: acquired 55,849 Common Stock, no par value at $3.30 ($184,302) on August 14, 2026; holds 156,152 after (Direct).
- Tax/exercise-price withholding: disposed of 48,629 Common Stock, no par value at $3.79 ($184,304) on August 14, 2026; holds 107,523 after (Direct).
- Option exercise/conversion: disposed of 55,849 Option to Purchase on August 14, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Regina Margaret Graul — Director, Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Option exercise/conversion | Common Stock, no par value | 55,849 | $3 | $184.3K | 156,152 |
| 2026-08-14 | Tax/exercise-price withholding | Common Stock, no par value | 48,629 | $4 | $184.3K | 107,523 |
| 2026-08-14 | Option exercise/conversion | Option to Purchase | 55,849 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Option exercise/conversion (55,849 shares) |
| 2026-08-14 | Tax/exercise-price withholding (48,629 shares) |
| 2026-08-14 | Option exercise/conversion (55,849 shares) |
Keywords
insider transaction, Form 4, CYCN, Cyclerion Therapeutics, Inc., neutral, Regina Margaret Graul
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.